Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombin III PK in neonates and infants on CPB or ECMO
NCT02631174Phase 1Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of antithrombin III in antithrombin III deficiency, sponsored by Cincinnati Children's Hospital Medical Center. Started Jun 2015; status: completed.
02
Drugs
antithrombin III
03
Conditions
antithrombin III deficiency
Beyond the preview
Go deeper on NCT02631174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631174.